Clinical Trial Update: Interferon-alpha Treatment of Chronic Cough in Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis [Phase 2]

View source ↗

Summary

A Phase 2 trial of interferon-alpha for chronic cough in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• Interferon-alpha (interferon alpha)

Snippet

Sponsor: Ainos, Inc. (f/k/a Amarillo Biosciences Inc. | Conditions: Pulmonary Disease, Chronic Obstructive, Pulmonary Fibrosis | Phase 2 | Status: TERMINATED